Literature DB >> 7910266

Evidence for glutamate excitotoxicity in Huntington's disease with proton magnetic resonance spectroscopy.

S D Taylor-Robinson, R A Weeks, J Sargentoni, C D Marcus, D J Bryant, A E Harding, D J Brooks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7910266     DOI： 10.1016/s0140-6736(94)90280-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging.

Authors:  L P Mark; R W Prost; J L Ulmer; M M Smith; D L Daniels; J M Strottmann; W D Brown; L Hacein-Bey
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

2.  Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.

Authors:  Paul G Unschuld; Richard A E Edden; Aaron Carass; Xinyang Liu; Megan Shanahan; Xin Wang; Kenichi Oishi; Jason Brandt; Susan S Bassett; Graham W Redgrave; Russell L Margolis; Peter C M van Zijl; Peter B Barker; Christopher A Ross
Journal:  Mov Disord       Date:  2012-05-30       Impact factor: 10.338

3.  Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study.

Authors:  L Harms; H Meierkord; G Timm; L Pfeiffer; A C Ludolph
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

4.  In Vitro Differentiation of Human Neural Progenitor Cells Into Striatal GABAergic Neurons.

Authors:  Lin Lin; Juan Yuan; Bjoern Sander; Monika M Golas
Journal:  Stem Cells Transl Med       Date:  2015-05-13       Impact factor: 6.940

Review 5.  Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.

Authors:  Y Y Hsu; A T Du; N Schuff; M W Weiner
Journal:  J Geriatr Psychiatry Neurol       Date:  2001       Impact factor: 2.680

6.  MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra.

Authors:  S D Taylor-Robinson; J Sargentoni; A Oatridge; D J Bryant; J V Hajnal; C D Marcus; J P Seery; H J Hodgson; N M deSouza
Journal:  Metab Brain Dis       Date:  1996-09       Impact factor: 3.584

7.  Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy.

Authors:  S D Taylor-Robinson; J Sargentoni; C D Marcus; M Y Morgan; D J Bryant
Journal:  Metab Brain Dis       Date:  1994-12       Impact factor: 3.584

8.  1H MR spectroscopy of the brain in HIV-1-seropositive subjects: evidence for diffuse metabolic abnormalities.

Authors:  C D Marcus; S D Taylor-Robinson; J Sargentoni; J G Ainsworth; G Frize; P J Easterbrook; S Shaunak; D J Bryant
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

Review 9.  Some methodological issues in neuroradiological research in psychiatry.

Authors:  T Becker; W Retz; E Hofmann; G Becker; E Teichmann; W Gsell
Journal:  J Neural Transm Gen Sect       Date:  1995

10.  Role of nitric oxide and cyclic GMP in glutamate-induced neuronal death.

Authors:  C Montoliu; M Llansola; P Monfort; R Corbalan; I Fernandez-Marticorena; M L Hernandez-Viadel; V Felipo
Journal:  Neurotox Res       Date:  2001-04       Impact factor: 3.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.